CAS: 637-07-0; Ethyl 2-(4-Chlorophenoxy)-2-Methylpropanoate

该化合物是一种合成化合物,被归类为纤维化,主要用作脂质低化剂处理超脂性贫血,其化学配方为C12H15ClO3, 其特点是氯化芳香环结构,有助其药理特性. 氯纤维素功能,通过激活过氧化性扩散器活性受体(PPPARs),导致脂肪酸氧化作用增加,血液中三重液水平下降.它通常通过口服进行,以降低胆固醇水平,特别是低密度脂蛋白(LDL)和三重甘酸盐含量的能力为人知,同时可能提高高密度脂质(HDL)水平.然而,由于对副作用的关切,包括胃肠扰动和潜在肝脏毒性,氯纤维酸盐的使用有所减少. 氯纤维酸盐也与凝固石的风险增加有关,因此通常被新剂取代,而其安全性素水平则得到改善.尽管其临床研究减少了,但其替代品仍是一种显著的化合物.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号600-00-0 2-溴-2-甲基丙酸乙酯 | CAS号106-48-9 对氯苯酚 | CAS号64-17-5 乙醇 | CAS号5542-60-9 2-(4-氯丙氧基)-2-甲基丙酰氯 | CAS号882-09-7 2-(4-氯苯氧基)异丁酸 | CAS号1193-00-6 对氯苯酚钠 | CAS号67-66-3 氯仿 | CAS号67-64-1 丙酮 | CAS号2052-01-9 2-溴代异丁酸 | CAS号141-52-6 乙醇钠 | CAS号18672-07-6 Ethyl 2-(4-cyan... | CAS号18672-04-3 Ethyl 2-methyl-... | CAS号29771-66-2 OTAVA-BB BB7216... | CAS号882-09-7 2-(4-氯苯氧基)异丁酸 | CAS号64-17-5 乙醇

合成工艺路线路线简述

  • 合成目标产物 Clofibrate 主要起始原料 Ethyl 2-Bromoisobutyrate And 4-Chlorophenol
  • (文献来源)合成步骤主要原料 Ethyl 2-Bromoisobutyrate 和 4-Chlorophenol
Sodium 4-Chlorophenolate置于吡啶,氯化亚砜,乙醇,氯仿,苯体系中,化学反应生成 氯贝特
参考文献:Julia,Bulletin De La Societe Chimique De France,1956,P. 776,780,781
标题:Julia,Bulletin De La Societe Chimique De France,1956,P. 776,780,781

海关参考信息

专利信息


专利号:US-10925977-B2
优先权日:2006-10-05
标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

专利号:US-10005720-B2
优先权日:2013-04-05
标题:Compounds useful for the treatment of metabolic disorders and synthesis of the same
发明人:SEXTON JONATHAN Z; BRENMAN JAY E; MUSSO DAVID L
权利人:NORTH CAROLINA CENTRAL UNIV; UNIV NORTH CAROLINA CHAPEL HILL
摘要:The present invention provides compounds of Formula (I): wherein variables X, Y, Z and R1 are as described herein. Some of the compounds described herein are glutamate dehydrogenase activators. The invention is also directed to pharmaceutical compositions comprising these compounds, uses of these compounds and compositions in the treatment of metabolic disorders as well as synthesis of the compounds.

专利号:US-2008287407-A1
优先权日:2003-12-10
标题 :Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use
发明人:GARVEY DAVID S; FANG XINQIN; KHANAPURE SUBHASH P; RANATUNGA RAMANI R; WEY SHIOW-JYI
权利人:NITROMED INC
摘要:The invention describes novel nitrosated and/or nitrosylated pyruvate compounds and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated and/or nitrosylated pyruvate compound, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one pyruvate compound and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one pyruvate compound, that is optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating diseases resulting from oxidative stress, diabetes, reperfusion injury following ischemia, preservation of tissues, organs, organ parts and/or limbs.

专利号:US-2009053804-A1
优先权日:2007-07-27
标题:Methods of reducing intracellular fats from mammalian cells
发明人:RUIZ JOSEPH CHARLES
权利人:VESTA THERAPEUTICS INC
摘要:The present invention provides methods of reducing or clearing fat from mammalian cells. The method comprises culturing the cells in an environment that facilitates: 1) reduction of de novo fatty acid synthesis, 2) activation or synthesis of fatty acid oxidizing enzymes, and/or 3) export of lipids out of the cells. Cells substantially free of fatty acid are also provided in this invention.

专利号:US-8846916-B2
优先权日:2009-05-11
标题:Sitagliptin synthesis
发明人:GORE VINAYAK GOVIND; GADAKAR MAHESHKUMAR; BHOSLE PRIYANKA; SHINDE SURESH
权利人:GORE VINAYAK GOVIND; GADAKAR MAHESHKUMAR; BHOSLE PRIYANKA; SHINDE SURESH; GENERICS UK LTD
摘要:The present invention relates to novel processes for the preparation of enantiomerically enriched β-amino acid derivatives such as β-amino esters useful for the synthesis of enantiomerically enriched biologically active molecules such as sitagliptin. The key step involves the resolution of the racemate with mandelic acid.

专利号:US-2013243770-A1
优先权日:2005-10-14
标 题:Treating diabetes using inhibitors of il-1
发明人:LAU JESPER
权利人:NOVO NORDISK AS
摘要:The present invention describes a method of treating diabetes or metabolic syndrome with a compound that inhibits (a) IL-1, (b) the synthesis of IL-1, or (c) the release of IL-1.
邯郸市赵都精细化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.zdchem.com
电话: 0310-8748056👤
📞邯郸市赵都精细化工有限公司 ⚠️参考联系方式

销售电话:0310-8748056
邮箱:info@zdchem.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Chandran K, Goswami S, Sharma-Walia N. Implications of a peroxisome proliferator-activated receptor alpha (PPARα) ligand clofibrate in breast cancer. Oncotarget. 2015 Nov 26. doi: 10.18632/oncotarget.6402. [Epub ahead of print] doi: 10.1016/j.mrgentox.2015.01.002. Epub 2015 Jan 6. doi: 10.1186/s12917-015-0368-y.
4: Lin X, Jacobi S, Odle J. Transplacental induction of fatty acid oxidation in term fetal pigs by the peroxisome proliferator-activated receptor alpha agonist clofibrate. J Anim Sci Biotechnol. 2015 Mar 26;6(1):11. doi: 10.1186/s40104-015-0010-7. eCollection 2015.
5: Bai X, Lin X, Drayton J, Liu Y, Ji C, Odle J. Clofibrate increases long-chain fatty acid oxidation by neonatal pigs. J Nutr. 2014 Nov;144(11):1688-93. doi: 10.3945/jn.114.193169. Epub 2014 Sep 3. doi: 10.1007/s10695-014-9986-8. Epub 2014 Sep 12. doi: 10.2478/10004-1254-65-2014-2434. doi: 10.1038/aps.2013.193. Epub 2014 Feb 24.

合成参考文献


参考文献:10.2165/11319380-000000000-00000
摘要:Chatzizisis YS, Koskinas KC, Misirli G, Vaklavas C, Hatzitolios A, Giannoglou GD. Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment. Drug Saf. 2010 Mar 01;33(3):171–87. doi: 10.2165/11319380-000000000-00000.
参考文献:10.4103/0971-6866.80360
摘要:Rathore SS, Agarwal SK, Pande S, Mittal T, Mittal B. The impact of VKORC1-1639 G>A polymorphism on the maintenance dose of oral anticoagulants for thromboembolic prophylaxis in North India: A pilot study. Indian J Hum Genet. 2011 May;17 Suppl 1():S54–7.
参考文献:10.1111/j.1525-1594.2011.01249.x
摘要:Liu G, Wang W, Xie H, Che Y, Xue J, Wu Y, Zhou Q, Kong D. Improved neuronal survival of focal ischemia after delipid extracorporeal lipoprotein treatment in hyperlipidemic rabbits. Artif Organs. 2011 Jul;35(7):E145–54. doi: 10.1111/j.1525-1594.2011.01249.x.
参考文献:10.1155/2011/937843
摘要:Shirinsky IV, Shirinsky VS. Targeting Nuclear Hormone Receptors: PPARαAgonists as Potential Disease-Modifying Drugs for Rheumatoid Arthritis. International Journal of Rheumatology. 2011;2011():1–8. doi: 10.1155/2011/937843.
参考文献:10.1186/1746-4269-7-22
摘要:Alves RR, Souto WM. Ethnozoology in Brazil: current status and perspectives. Journal of Ethnobiology and Ethnomedicine. 2011 Jul 18;7(1):22. doi: 10.1186/1746-4269-7-22.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知